Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LOVENOX
- Lovenox With Aspirin in Thawed Blastocyst Transfer
- A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants
- Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures
- Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)
- Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)
- Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
- Enoxaparin Bioequivalence Study in Acute Coronary Syndrome Patients
- Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)
- Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®
- Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients
- Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19
- Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery
- Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban
- Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement
- Below Knee DVT Study
- The Erector Spinae Plane Block and Its Effect on Respiratory Status and Pain Management in Rib Fracture Patients
- Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin
- Low Molecular Weight Heparin (LMWH) vs Aspirin for Venous Thromboembolism (VTE) Prophylaxis in Orthopaedic Oncology
- Timing of VTE Prophylaxis in TBI
- Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial
- A Different Approach to Preventing Thrombosis
- Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
- Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients
- Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients
- Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial
- Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox®
- The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study
- Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy
- Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
- OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage - Pilot Study
- Enoxamed Study in the Treatment of Acute Coronary Syndromes
- Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis
- Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis
- Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors
- Enoxaparin Dosing in Obesity
- Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS-FXIRx in Total Knee Arthroplasty
- Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology
- Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome
- OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage (OPTTTICH Feasibility Study)
- Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma
- Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin
- Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery
- Thrombelastography Based Dosing of Enoxaparin
- A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)
- Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
- Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients
- Enoxaparin and/or Minocycline in Acute Stroke
- Anticoagulation Post Laparoscopic Splenectomy
- STEMI Treated With Primary Angioplasty and Intravenous Lovenox or Unfractionated Heparin (UFH)
- Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer
- Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT
- Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients
- Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients
- Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
- Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
- Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
- Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
- Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism
- Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)
- Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
- Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)
- Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)
Clinical trials list
click for details